Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical, Inc. (COLL) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · COLL · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
19
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Collegium Pharmaceutical, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
COLL insider buying and selling by quarter
COLL insider selling · COLL insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · COLL ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
COLL executive sell shares · COLL board member insider trading · COLL insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 18, 2026 | Freund John Gordon Director | Sale | 20 | $681 | Form 4 |
| May 14, 2026 | Lurker Nancy Director | Award | 8,741 | — | Form 4 |
| May 14, 2026 | Paya Carlos V Director | Award | 8,741 | — | Form 4 |
| May 15, 2026 | Freund John Gordon Director | Option | 8,700 | $143K | Form 4 |
| May 15, 2026 | Freund John Gordon Director | Sale | 4,127 | $143K | Form 4 |
| May 14, 2026 | Freund John Gordon Director | Award | 8,741 | — | Form 4 |
| May 14, 2026 | BOHLIN GAREN G Director | Award | 8,741 | — | Form 4 |
| May 14, 2026 | Glancy Donovan Michael Director | Award | 17,482 | — | Form 4 |
| May 14, 2026 | Balice-Gordon Rita J. Director | Award | 8,741 | — | Form 4 |
| May 14, 2026 | SANTINI GINO Director | Award | 8,741 | — | Form 4 |
| May 13, 2026 | Lurker Nancy Director | Sale | 4,500 | $162K | Form 4 |
| May 11, 2026 | BOHLIN GAREN G Director | Option | 8,700 | $143K | Form 4 |
| May 11, 2026 | BOHLIN GAREN G Director | Sale | 8,700 | $323K | Form 4 |
| Mar 17, 2026 | Dieter David EVP & General Counsel | Other | 8,840 | $316K | Form 4 |
| Mar 18, 2026 | Dieter David EVP & General Counsel | Sale | 13,976 | $488K | Form 4 |
| Mar 3, 2026 | Dreyer Scott EVP & Chief Commercial Officer | Sale | 46,417 | $1.87M⚡ | Form 4 |
| Mar 3, 2026 | Dreyer Scott EVP & Chief Commercial Officer | Sale | 3,559 | $146K | Form 4 |
| Feb 10, 2026 | Dieter David EVP & General Counsel | Award | 9,005 | — | Form 4 |
| Feb 10, 2026 | Dieter David EVP & General Counsel | Other | 2,781 | $130K | Form 4 |
| Feb 10, 2026 | Dieter David EVP & General Counsel | Award | 22,194 | — | Form 4 |
| Feb 10, 2026 | Karnani Vikram President and CEO · Director | Award | 32,531 | — | Form 4 |
| Feb 10, 2026 | Karnani Vikram President and CEO · Director | Other | 11,296 | $528K | Form 4 |
| Feb 10, 2026 | Karnani Vikram President and CEO · Director | Award | 79,264 | — | Form 4 |
| Feb 10, 2026 | Smith Thomas B EVP and Chief Medical Officer | Award | 22,774 | — | Form 4 |
| Feb 10, 2026 | Smith Thomas B EVP and Chief Medical Officer | Other | 5,897 | $276K | Form 4 |
Dieter David
EVP & General Counsel
Date
Mar 17
Shares
8,840
Price
$35.72
Value
$316K
Dieter David
EVP & General Counsel
Date
Mar 18
Shares
13,976
Price
$34.92
Value
$488K
Dreyer Scott
EVP & Chief Commercial Officer
Date
Mar 3
Shares
46,417
Price
$40.36
Value
$1.87M ⚡
Dreyer Scott
EVP & Chief Commercial Officer
Date
Mar 3
Shares
3,559
Price
$40.99
Value
$146K
Dieter David
EVP & General Counsel
Date
Feb 10
Shares
2,781
Price
$46.75
Value
$130K
Karnani Vikram
President and CEO · Director
Date
Feb 10
Shares
32,531
Price
—
Value
—
Karnani Vikram
President and CEO · Director
Date
Feb 10
Shares
11,296
Price
$46.75
Value
$528K
Karnani Vikram
President and CEO · Director
Date
Feb 10
Shares
79,264
Price
—
Value
—
Smith Thomas B
EVP and Chief Medical Officer
Date
Feb 10
Shares
22,774
Price
—
Value
—
Smith Thomas B
EVP and Chief Medical Officer
Date
Feb 10
Shares
5,897
Price
$46.75
Value
$276K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About COLL insider trading
COLL insider trades
Collegium Pharmaceutical, Inc. (COLL) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Dreyer Scott (EVP & Chief Commercial Officer), Freund John Gordon (Director), Tupper Colleen (EVP & Chief Financial Officer). Over the past 12 months, 5 insiders have filed transactions with the SEC. COLL insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Collegium Pharmaceutical, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
COLL insider trading · 5 questionsThe insiders of Collegium Pharmaceutical, Inc. (COLL) include executives and directors such as Dreyer Scott (EVP & Chief Commercial Officer), Freund John Gordon (Director), Tupper Colleen (EVP & Chief Financial Officer), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026